Access cutting-edge type 2 diabetes treatment through this clinical trial at a research site in Riverside. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Riverside location
Access type 2 diabetes specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related type 2 diabetes treatment provided free
Check if you qualify for this type 2 diabetes clinical trial in Riverside, CA
No-Cost Study Care
Local to Riverside
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study is designed to test how well once-weekly MET097 (an ultra-long-acting GLP-1 receptor agonist) works to treat adults with obesity or overweight and type 2 diabetes mellitus (T2DM) compared to placebo. MET097 or placebo will be administered to individuals via subcutaneous injection once weekly for 28 weeks. If an individual is randomly assigned to MET097 they will receive one of four different dose regimens.
Sponsor: Metsera
Yes, this clinical trial (NCT06897202) has an active research site in Riverside, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for type 2 diabetes treatment options in Riverside, CA, this clinical trial (NCT06897202) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Riverside research site is actively enrolling participants for this clinical trial. You'll receive care from experienced type 2 diabetes specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all type 2 diabetes clinical trials near you to find additional studies recruiting in your area.
See all pulmonary embolism clinical trials recruiting in Riverside — not just this study.
Browse Pulmonary Embolism Trials in Riverside →